BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 34208339)

  • 21. Rationale for immune-based therapies in Merkel polyomavirus-positive and -negative Merkel cell carcinomas.
    Vandeven N; Nghiem P
    Immunotherapy; 2016 Jul; 8(8):907-21. PubMed ID: 27381685
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regression of metastatic Merkel cell carcinoma following transfer of polyomavirus-specific T cells and therapies capable of re-inducing HLA class-I.
    Chapuis AG; Afanasiev OK; Iyer JG; Paulson KG; Parvathaneni U; Hwang JH; Lai I; Roberts IM; Sloan HL; Bhatia S; Shibuya KC; Gooley T; Desmarais C; Koelle DM; Yee C; Nghiem P
    Cancer Immunol Res; 2014 Jan; 2(1):27-36. PubMed ID: 24432305
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correlation of Merkel cell polyomavirus positivity with PDGFRα mutations and survivin expression in Merkel cell carcinoma.
    Batinica M; Akgül B; Silling S; Mauch C; Zigrino P
    J Dermatol Sci; 2015 Jul; 79(1):43-9. PubMed ID: 25936870
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recent Therapeutic Advances and Change in Treatment Paradigm of Patients with Merkel Cell Carcinoma.
    Garcia-Carbonero R; Marquez-Rodas I; de la Cruz-Merino L; Martinez-Trufero J; Cabrera MA; Piulats JM; Capdevila J; Grande E; Martin-Algarra S; Berrocal A
    Oncologist; 2019 Oct; 24(10):1375-1383. PubMed ID: 30962295
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Merkel cell polyomavirus infection, large T antigen, retinoblastoma protein and outcome in Merkel cell carcinoma.
    Sihto H; Kukko H; Koljonen V; Sankila R; Böhling T; Joensuu H
    Clin Cancer Res; 2011 Jul; 17(14):4806-13. PubMed ID: 21642382
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Merkel cell carcinoma: a highly aggressive tumor with possible viral etiology].
    Toberer F; Werchau S; Bischof M; Büchler M; Enk A; Helmbold P
    Chirurg; 2011 Aug; 82(8):653-60. PubMed ID: 21290092
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A review on the oncogenesis of Merkel cell carcinoma: Several subsets arise from different stages of differentiation of stem cell.
    Zhu Y; Yin Y; Li F; Ren Z; Dong Y
    Medicine (Baltimore); 2023 Apr; 102(15):e33535. PubMed ID: 37058042
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Update on the biology and clinical management of Merkel cell carcinoma.
    Thakuria M; LeBoeuf NR; Rabinowits G
    Am Soc Clin Oncol Educ Book; 2014; ():e405-10. PubMed ID: 24857131
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Merkel Cell Carcinoma in the Age of Immunotherapy: Facts and Hopes.
    Colunga A; Pulliam T; Nghiem P
    Clin Cancer Res; 2018 May; 24(9):2035-2043. PubMed ID: 29217527
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Usefulness of ulceration and hyperkeratosis as clinical predictors of Merkel cell polyomavirus-negative and combined Merkel cell carcinoma: A retrospective study.
    Nagase K; Kimura-Kaku H; Inoue T; Shinogi T; Narisawa Y
    J Dermatol; 2019 Feb; 46(2):103-109. PubMed ID: 30565285
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantitative analysis of viral load per haploid genome revealed the different biological features of Merkel cell polyomavirus infection in skin tumor.
    Ota S; Ishikawa S; Takazawa Y; Goto A; Fujii T; Ohashi K; Fukayama M
    PLoS One; 2012; 7(6):e39954. PubMed ID: 22768181
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multidisciplinary Treatment, Including Locoregional Chemotherapy, for Merkel-Polyomavirus-Positive Merkel Cell Carcinomas: Perspectives for Patients Exhibiting Oncogenic Alternative Δ exon 6-7 TrkAIII Splicing of Neurotrophin Receptor Tropomyosin-Related Kinase A.
    Guadagni S; Farina AR; Cappabianca LA; Sebastiano M; Maccarone R; Zelli V; Clementi M; Chiominto A; Bruera G; Ricevuto E; Fiorentini G; Sarti D; Mackay AR
    Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33153070
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Merkel cell carcinoma: cutaneous manifestation of a highly malignant pre-/pro-B cell neoplasia? : Novel concept about the cellular origin of Merkel cell carcinoma].
    Sauer CM; Chteinberg E; Rennspiess D; Kurz AK; Zur Hausen A
    Hautarzt; 2017 Mar; 68(3):204-210. PubMed ID: 28194491
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quality Is King: Fundamental Insights into Tumor Antigenicity from Virus-Associated Merkel Cell Carcinoma.
    Lahman MC; Paulson KG; Nghiem PT; Chapuis AG
    J Invest Dermatol; 2021 Aug; 141(8):1897-1905. PubMed ID: 33863500
    [TBL] [Abstract][Full Text] [Related]  

  • 35. RB1 is the crucial target of the Merkel cell polyomavirus Large T antigen in Merkel cell carcinoma cells.
    Hesbacher S; Pfitzer L; Wiedorfer K; Angermeyer S; Borst A; Haferkamp S; Scholz CJ; Wobser M; Schrama D; Houben R
    Oncotarget; 2016 May; 7(22):32956-68. PubMed ID: 27121059
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Investigation of the RB1-SOX2 axis constitutes a tool for viral status determination and diagnosis in Merkel cell carcinoma.
    Thanguturi S; Tallet A; Miquelestorena-Standley E; Coco C; Le Corre Y; Hainaut-Wierzbicka E; Blom A; Saiag P; Beneton N; Bens G; Zaragoza J; Nardin C; Aubin F; Dinulescu M; Machet MC; Houben R; Schrama D; Collin C; Fromont G; Jullie ML; Macagno N; Gaboriaud P; Berthon P; Touzé A; Guyétant S; Samimi M; Kervarrec T
    Virchows Arch; 2022 Jun; 480(6):1239-1254. PubMed ID: 35412101
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Merkel cell polyomavirus-specific CD8⁺ and CD4⁺ T-cell responses identified in Merkel cell carcinomas and blood.
    Iyer JG; Afanasiev OK; McClurkan C; Paulson K; Nagase K; Jing L; Marshak JO; Dong L; Carter J; Lai I; Farrar E; Byrd D; Galloway D; Yee C; Koelle DM; Nghiem P
    Clin Cancer Res; 2011 Nov; 17(21):6671-80. PubMed ID: 21908576
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Merkel cell carcinoma: histopathologic and prognostic features according to the immunohistochemical expression of Merkel cell polyomavirus large T antigen correlated with viral load.
    Leroux-Kozal V; Lévêque N; Brodard V; Lesage C; Dudez O; Makeieff M; Kanagaratnam L; Diebold MD
    Hum Pathol; 2015 Mar; 46(3):443-53. PubMed ID: 25623078
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Merkel Cell Carcinoma Patients Presenting Without a Primary Lesion Have Elevated Markers of Immunity, Higher Tumor Mutation Burden, and Improved Survival.
    Vandeven N; Lewis CW; Makarov V; Riaz N; Paulson KG; Hippe D; Bestick A; Doumani R; Marx T; Takagishi S; Chan TA; Choi J; Nghiem P
    Clin Cancer Res; 2018 Feb; 24(4):963-971. PubMed ID: 29246939
    [No Abstract]   [Full Text] [Related]  

  • 40. Merkel Cell Carcinoma.
    Lewis DJ; Sobanko JF; Etzkorn JR; Shin TM; Giordano CN; McMurray SL; Walker JL; Zhang J; Miller CJ; Higgins HW
    Dermatol Clin; 2023 Jan; 41(1):101-115. PubMed ID: 36410971
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.